View of COMPARATIVE EFFICACY BETWEEN LONG-ACTING BETA-2 AGONISTS (LABA) AND LONG-ACTING MUSCARINIC ANTAGONISTS (LAMA) IN THE CLINICAL RESPONSE OF DPOC PATIENTS: A SYSTEMATIC REVIEW

Return to Issue Details COMPARATIVE EFFICACY BETWEEN LONG-ACTING BETA-2 AGONISTS (LABA) AND LONG-ACTING MUSCARINIC ANTAGONISTS (LAMA) IN THE CLINICAL RESPONSE OF DPOC PATIENTS: A SYSTEMATIC REVIEW Download Download PDF